Clinical Evidence

A Case Study: The Use of EndoTool in Obstetrics

Setting: 1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results

Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.

Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.

Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results

Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.

Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.

References

Authors

Maresa Glass, PharmD, BCPS, BCCCP.

Source

Presented at EndoTool® User Group Meeting.

Year

2018

Download

Quick navigation

Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results

Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.

Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.